戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1                       In behavioral studies, intraplantar 0.1 microM APDC, a group II agonist, signif
2 Intrathecal (1-100 microg/5 microl), but not intraplantar (10 or 100 microg/50 microl), injection of
3   Inflammatory sensitization was produced by intraplantar administration of capsaicin, formalin or co
4 ement deficiencies, we demonstrated that the intraplantar administration of KLK14 results in C3-assoc
5            Pain hypersensitivity elicited by intraplantar administration of prostaglandin E2, bradyki
6                                     In mice, intraplantar administration of TAT-pQYP decreased mechan
7                                              Intraplantar administration of zymosan produces inflamma
8 inal dorsal horn neurons to thermal stimuli, intraplantar administration of zymosan resulted in signi
9 ses of primary afferents to thermal stimuli, intraplantar administration of zymosan resulted in signi
10 ther thermal or mechanical stimuli following intraplantar administration of zymosan.
11 no change or were increased significantly by intraplantar administration of zymosan.
12                                              Intraplantar adoptive transfer of paclitaxel-activated m
13                                              Intraplantar and intrathecal injection of bile acids cau
14                                              Intraplantar and intrathecal injection of the TLR9 agoni
15                           In wild-type mice, intraplantar and intravenous hIAPP injections induced lo
16 luence the formation of edema, caused by the intraplantar application of polysaccharide lambda-carrag
17  0.1 mg prostaglandin E(2) (PGE(2)) into the intraplantar area of the rat paw produced thermal hypers
18 his effect is dose-dependently attenuated by intraplantar but not by intravenous alpha-helical CRF.
19                                              Intraplantar but not systemic injection of the ET-A rece
20                                        Using intraplantar capsaicin injection as an acute peripheral
21 ecally injected GABA receptor agonists after intraplantar capsaicin injection prevented the vibration
22 oreover, chemogenetic activation of BG or an intraplantar capsaicin injection reduced Purkinje cell f
23                Conversely, in the absence of intraplantar capsaicin injection, intrathecally injected
24  flares were also elicited in response to an intraplantar capsaicin injection.
25 s-induced antinociception (NSIA) produced by intraplantar capsaicin injection.
26                              The response to intraplantar capsaicin is substantially reduced, as expe
27                                              Intraplantar capsaicin produced dose- and time-related p
28 eftward shift in the dose-response curve for intraplantar capsaicin-induced inhibition of synovial pl
29 were examined over a 6-h period following an intraplantar carrageenan (0.0-1.0%) injection.
30  inhibitor) or NS398 (COX-2 inhibitor) after intraplantar carrageenan administration.
31  the most notable increases that occur after intraplantar carrageenan are metabolites of 12-lipoxygen
32 nal cord 2h, 1 day, 3 days, and 7 days after intraplantar CFA injection and in the ipsilateral L4/5 d
33                                              Intraplantar CFA or intrathecal infusion of recombinant
34                                              Intraplantar co-application of flagellin and QX-314 (fla
35                                              Intraplantar coadministration of the TRPA1 receptor anta
36 mg/kg, i.p.), and thermal hyperalgesia after intraplantar complete Freund's adjuvant injection (ED(50
37 ebroventricular (ED(50)>100 nmol, i.c.v.) or intraplantar (ED(50)>500 nmol) routes suggesting that sp
38                                        After intraplantar, facial or lingual injection, Lgmn evoked n
39 rotonergic neurons was used to examine if an intraplantar formalin injection (an acute noxious input)
40     However, injury-induced pain produced by intraplantar formalin is reduced by 70%.
41                           Animals exposed to intraplantar formalin or bradykinin injection exhibited
42                                              Intraplantar Formalin, known to elevate extracellular GL
43 ice showed a 70% reduction in phase 2 of the intraplantar formalin-evoked pain response but only a mo
44 en evaluated behavioral responses to noxious intraplantar formalin.
45 cant reduction of mechanical allodynia after intraplantar Freund's adjuvant (CFA).
46                            Pretreatment with intraplantar galanin and bradykinin, compounds known to
47                          In support of this, intraplantar GLU + LY produced heat hyperalgesia, and ex
48 inally, the pain hypersensitivity induced by intraplantar IL-1beta was reduced in CKO mice.
49                                              Intraplantar IL-6 induced hypersensitivity was similar i
50 f the mammalian EGF receptor ErbB1, and that intraplantar injection in mice causes long-lasting hyper
51 eversing spontaneous pain induced in mice by intraplantar injection in OD1, a scorpion toxin that pot
52                                              Intraplantar injection in rats of the ONOO(-) precursor
53                                              Intraplantar injection of 0.1 or 1 mM S-DHPG results in
54                                              Intraplantar injection of 100 microg anandamide produced
55                                              Intraplantar injection of 40 microM AIDA+2% formalin sig
56                                              Intraplantar injection of a higher dose of URB597 (100 m
57 gnaling was underscored by the findings that intraplantar injection of a monoclonal PGE(2) antibody (
58                                              Intraplantar injection of a PAR2 agonist caused persiste
59 erved significant priming effects 3 hrs post intraplantar injection of a subthreshold dose of prostag
60                                              Intraplantar injection of AEA (10 mug/10 mul) or URB597
61                                              Intraplantar injection of AEA reduced the hyperalgesia,
62                Furthermore, we determined if intraplantar injection of anandamide altered withdrawal
63                                      Neither intraplantar injection of anandamide nor vehicle produce
64        Blocking peripheral mGluR activity by intraplantar injection of antagonists LY341495 [(2S)-2-a
65                                              Intraplantar injection of capsaicin (0.05%) significantl
66                        Similar to PGE(2), an intraplantar injection of capsaicin (0.1 mg) produced a
67                                              Intraplantar injection of capsaicin in an intact animal
68                                              Intraplantar injection of capsaicin produced an increase
69 olestanol inhibited nociceptive responses to intraplantar injection of capsaicin, formalin, or comple
70 ansiently inhibited nociceptive responses to intraplantar injection of capsaicin.
71 nished the responses of remaining neurons to intraplantar injection of capsaicin.
72 odel of inflammation-related hyperalgesia by intraplantar injection of carrageenan in rats, inhibitio
73                                              Intraplantar injection of Cat-S caused inflammation and
74 hat, in addition to mechanical hyperalgesia, intraplantar injection of ceramide (10 mug) led to the d
75  recorded in slices from rats inflamed by an intraplantar injection of complete Freund's adjuvant (CF
76 levated during skin inflammation produced by intraplantar injection of complete Freund's adjuvant (CF
77  Persistent inflammatory pain was induced by intraplantar injection of complete Freund's adjuvant (CF
78 preclinical models of inflammatory pain: (i) intraplantar injection of complete Freund's adjuvant (CF
79                                      Hindpaw intraplantar injection of complete Freund's adjuvant (CF
80 to an inflamed paw [1 h, 1 d, or 5-6 d after intraplantar injection of Complete Freund's Adjuvant (CF
81 n by persistent inflammatory pain induced by intraplantar injection of complete Freund's adjuvant (CF
82 nflammation and hyperalgesia were induced by intraplantar injection of complete Freund's adjuvant.
83                                              Intraplantar injection of dilute formalin evokes brief (
84                                              Intraplantar injection of either capsazepine (10 microg)
85                                 Furthermore, intraplantar injection of either H(2)O(2) or 15d-PGJ2 ev
86                                              Intraplantar injection of elastase to mice caused edema
87                                              Intraplantar injection of ET-1 in naive and, to a greate
88 duces inflammatory pain behaviors induced by intraplantar injection of formalin, carrageenan or compl
89 aint and MAP, HR and behavioral responses to intraplantar injection of formalin.
90 icking, and lifting responses resulting from intraplantar injection of formalin.
91 duced pain-related behaviours in response to intraplantar injection of formalin.
92                                     In mice, intraplantar injection of HQ at clinically relevant conc
93                                              Intraplantar injection of icilin did not evoke firing of
94                                              Intraplantar injection of IL-6 followed immediately by i
95  after the induction of inflammation with an intraplantar injection of lambda-carrageenan.
96                                              Intraplantar injection of let-7b elicits rapid spontaneo
97 ly, we tested cold sensitivity in mice after intraplantar injection of lysophosphatidic acid or 4-hyd
98 ersensitivity and spontaneous pain evoked by intraplantar injection of melanoma or lung carcinoma cel
99 ral thermal sensitization in mice induced by intraplantar injection of mGlu1/5 agonists was also bloc
100                                              Intraplantar injection of mice with CCL3 decreased their
101                                 The combined intraplantar injection of non-algesic doses of PAR2 agon
102                                              Intraplantar injection of PAR(2) agonist also caused pho
103                                              Intraplantar injection of PAR2 agonist caused mechanical
104                                              Intraplantar injection of PD-L1 evoked analgesia in naiv
105 tion of IL-6-induced allodynia, a subsequent intraplantar injection of prostaglandin E(2) (PGE(2)) or
106 t hind paw with a profile similar to that of intraplantar injection of prostaglandin E2 (PGE2), which
107                   Conversely, intrathecal or intraplantar injection of recombinant FST, or overexpres
108                               Intravenous or intraplantar injection of RP67580 (6.8 nmol) did not aff
109 y NF-kappaB and p38 kinase activation, since intraplantar injection of SC-514 (0.1-1 mug) or SB 20358
110  was further supported by demonstrating that intraplantar injection of soluble ONOO(-) itself (1 micr
111                                 Furthermore, intraplantar injection of SRIF antiserum also results in
112                  In a dose-dependent manner, intraplantar injection of the SRIF receptor antagonist c
113 n Frey system was used, following unilateral intraplantar injection of TNFalpha or intraarticular inj
114 jection of AEA reduced the hyperalgesia, and intraplantar injection of URB597, an inhibitor of FAAH,
115 yperalgesia, but not inflammation, following intraplantar injection.
116                                              Intraplantar injections of EP2 or BK2 agonists inhibited
117             To test this hypothesis, we used intraplantar injections of interleukin-6 (IL-6) in mice
118              Here, we have demonstrated that intraplantar injections of low dose STZ evoked acute pol
119 cutaneous), spinal (intrathecal) or hindpaw (intraplantar) injections of test compounds, we determine
120                                              Intraplantar inoculation of a WT strain of MAYV into imm
121 nflammatory injury, in this case produced by intraplantar (ipl) injection of complete Freund's adjuva
122                                              Intraplantar microinjection of TIP39 caused a paw-withdr
123 blockade by resiniferatoxin failed to affect intraplantar ODN 1826-induced mechanical allodynia.
124 sensitivity observed in wild-type mice after intraplantar or intrathecal (spinal) administration of p
125                                 Furthermore, intraplantar or intrathecal administration of A-784168 b
126              Here we report that peripheral (intraplantar) or spinal (intrathecal) administration of
127 ll activation, and histopathology induced by intraplantar paw administration of a C3aR agonist.
128                                              Intraplantar pretreatment with either 5 mM dextrorphan (
129 dynia when exposed to a subthreshold dose of intraplantar Prostaglandin E(2) (PGE(2)) compared to mic
130                         In behavioral tests, intraplantar S-DHPG (0.1, 1.0, 10 mM) does not change ta
131                                              Intraplantar URB597 (25 microg in 50 microl) did not, ho
132                                              Intraplantar URB597 (25 microg in 50 microl) significant

 
Page Top